Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Bevacizumab in advanced non-squamous NSCLC (MIMEB)
NCT01047059Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Jan 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib, bevacizumab in non-small cell lung carcinoma (NSCLC), sponsored by University of Cologne. Started Jan 2010; status: completed.
02
Drugs
erlotinibbevacizumab
03
Conditions
non-small cell lung carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT01047059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01047059.